AFA
AMED

Abacus FCF Advisors’s Amedisys AMED Stock Holding History

Abacus FCF Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,087
Closed -$324K – 126
2021
Q3 		$324K Hold
2,087
– – 0.16% 133
2021
Q2 		$521K Sell
2,087
-154
-7% -$40.4K 0.27% 137
2021
Q1 		$607K Buy
+2,241
New +$632K 0.31% 123
2016
Q1 		– Sell
-55,157
Closed -$2.17M – 103
2015
Q4 		$2.17M Buy
+55,157
New +$2.21M 0.99% 53

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Abacus FCF Advisors's AMED Position: Q4 2021 in Review

Abacus FCF Advisors sold out of Amedisys (AMED) in Q4 2021, closing a stake of 2,087 shares — an estimated $324K sold.

Abacus FCF Advisors first reported a position in AMED in Q4 2015 and held it in 4 quarters. The position peaked at $2.17M in Q4 2015. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Abacus FCF Advisors reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Abacus FCF Advisors sold 2,087 Amedisys shares in Q4 2021, an estimated $324K.
  • Abacus FCF Advisors first reported a position in Amedisys in Q4 2015 and held it in 4 quarters.
  • Abacus FCF Advisors's Amedisys position peaked at $2.17M in Q4 2015.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Abacus FCF Advisors's 13F filing for Q4 2021, filed 10 Jan 2022.